Post Marketing Study of Safety and Efficacy of Crystalys, a Calcium Hydroxyapatite Based Filler for Facial Soft Tissue Augmentation
In this post marketing study our primary objective was to assess the safety of Crystalys, a new calcium hydroxyapatite based filler, in subjects who received sub-dermal or deep-dermal injections for facial soft tissue augmentation. The secondary objective was to evaluate the performance of Crystalys within six months of injection.
Hologic Completes Acquisition of Cynosure
„We are pleased to complete our acquisition of Cynosure, and look forward to working with Michael Davin and the entire Cynosure team to achieve even greater success in the large, rapidly growing medical aesthetics market,“ said Steve MacMillan, Hologic‘s Chairman, President and Chief Executive Officer. „Acquiring Cynosure, combined with divesting our blood screening business, fundamentally reshapes our business portfolio and makes us […]
Merck Initiates Phase III Study of MSB11022, a Proposed Biosimilar of Adalimumab, in Chronic Plaque Psoriasis
Darmstadt, Germany – Merck, a leading science and technology company, announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This milestone is a strong reflection of Merck’s progress in biosimilars, with the goal of delivering high-quality biologics to patients all over the world. […]
Allergan Symposium at the 13. AMWC in Monaco: The day long symposium under the guidance of Dr. Koenraad de Boulle from Belgium was dedicated to the motto „Achieving real expressions in challenging patients“. Customized approaches to facial rejuvenation to achieve a natural look, were presented. Mauricio de Maio from Brazil presented several difficult cases […]